Historical cohort evaluation of ribavirin efficacy in respiratory syncytial virus infection

Clicks: 372
ID: 117815
1993
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #25 of 46 articles by views in the pediatric infectious disease journal

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Evaluation of ribavirin therapy for respiratory syncytial virus infection of the lower respiratory tract is problematic because of multiple risk factors and variable severity of illness in respiratory syncytial virus-infected patients. To address these difficulties we used multivariate analysis and …
Reference Key
jg1993thehistorical Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Wheeler JG;Wofford J;Turner RB;;
Journal the pediatric infectious disease journal
Year 1993
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/8451097
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine female male Infant newborn Cohort Studies multivariate analysis ribavirin / therapeutic use* respirovirus infections / drug therapy* respiratory syncytial viruses* pmid:8451097 doi:10.1097/00006454-199303000-00007 j g wheeler j wofford r b turner

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.